HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

HERBALIFE LTD.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$13.88−0.72 (-4.93%)

Close on Oct 19, 2026

Market cap: $1.45B
P/E (TTM): 9.0
Dividend yield: –

HERBALIFE LTD. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	5,038	4,993	5,062	5,204	5,803	5,542	4,877	4,892	4,428	4,488	4,469	4,959	4,825	4,072	3,455	2,734	2,325	2,359
Cost of Revenue	1,115	1,104	1,191	1,174	1,239	1,151	958	919	849	855	856	983	963	813	680	559	493	458
Gross Profit	3,923	3,889	3,871	4,031	4,564	4,391	3,919	3,973	3,579	3,634	3,613	3,976	3,862	3,260	2,774	2,175	1,831	1,901
Selling, General & Admin	–	1,875	1,866	1,810	2,012	2,075	1,940	1,955	1,759	1,967	1,785	1,991	1,629	1,260	1,075	888	774	772
General & Administrative	1,664	1,726	1,701	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Advertising Expenses	42	46	54	47	47	39	41	41	56	65	66	70	58	42	38	31	–	–
Operating Income	481	386	356	545	734	641	568	683	617	458	584	514	735	661	562	388	296	332
Interest Expense	214	218	166	139	153	133	153	181	161	99	101	92	27	17	9.86	9.66	9.61	–
Interest & Investment Income	–	–	–	–	–	–	–	–	15	5.90	5.60	13	8.00	6.20	7.37	2.25	4.51	6.89
Other Non-Operating Income	0	-11	1.00	13	-25	0	-16	-57	0.40	–	-2.30	-13	–	–	–	–	–	–
Merger & Restructuring Charges	7.00	69	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	–	–	–	0	–	0	0	0	0	0	0	0	0	0	0	–	–	–
Pretax Income	275	169	203	425	561	516	451	464	471	365	486	421	717	651	560	380	291	319
Income Tax Expense	47	-85	61	104	114	144	140	168	257	105	147	113	189	187	145	87	88	98
Net Income incl. Noncontrolling Interests	228	254	142	321	447	373	311	297	214	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	-0.50	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	228	254	142	321	447	373	311	297	214	260	339	309	528	464	415	293	203	221
EPS (Basic)(per share)	2.22	2.53	1.44	3.26	4.22	2.83	2.26	2.12	1.35	1.57	2.06	1.79	2.57	2.07	1.77	1.23	0.83	0.87
EPS (Diluted)(per share)	2.20	2.50	1.42	3.23	4.13	2.77	2.20	1.98	1.29	1.51	1.99	1.70	2.46	1.97	1.66	1.16	0.81	0.84
Shares Outstanding (Basic, Weighted)(shares)	103	101	99	99	106	132	137	140	159	166	165	173	205	225	235	238	245	255
Shares Outstanding (Diluted, Weighted)(shares)	104	102	100	100	108	135	142	150	166	172	171	182	215	236	250	253	252	263
Dividend per Share(per share)	–	–	–	–	–	–	–	–	–	–	–	0.15	0.60	0.60	0.37	0.23	0.20	0.20
EBITDA	602	507	470	661	842	741	666	784	717	556	682	607	820	736	634	456	358	381

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 77.7%
Operating margin: 9.5%
Net margin: 3.2%
Return on equity, FY2025: -34.7%

Financial strength

Current ratio: 1.20
Debt to equity: -4.25
Debt to assets: 70.5%
Cash to current liabilities: 38.1%

Valuation

P/E ratio: 9.0
Price to sales: 0.28
Price to book: –
Dividend yield: –